Advertisement
Patients with peanut allergy who received oral immunotherapy

ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy

0
More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms
Rates of multiple sclerosis relapse decrease during pregnancy but increase postpartum

MS Relapse Drops During Pregnancy but Rises After

0
Disease-modifying drug use uncommon year before pregnancy and further drops during pregnancy
Opioid misuse varies with sexual orientation

Opioid Misuse Varies With Sexual Orientation

0
Prescription opioid misuse more likely for female respondents identifying as bisexual
A patient-centered education bundle intervention can reduce nonadministration of venous thromboembolism prophylaxis

Patient Education Ups VTE Prophylaxis in Hospital Setting

0
Targeted patient-centered intervention reduces nonadministration of pharmacologic prophylaxis
The prevalence of food allergy is 7.6 percent among children in the United States

Prevalence of Food Allergy 7.6 Percent in U.S. Children

0
Most prevalent allergens are peanut, milk, shellfish, and tree nut
There are great differences in access to naloxone even among states that have passed legislation to allow pharmacists to dispense the medication without a physician's prescription

Even With Standing Orders, Naloxone Access Varies

0
Despite standing order legislation in two states, there is great variance in pharmacy availability
The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral T-cell lymphoma.

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

0
Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma
Use of sodium glucose cotransporter 2 inhibitors is associated with an increased risk for lower-limb amputation and diabetic ketoacidosis compared with use of glucagon-like peptide 1 receptor agonists

Higher Risk for Amputation, DKA With SGLT2 Inhibitors for T2DM

0
Risk increased for lower-limb amputation, diabetic ketoacidosis compared with GLP1 receptor agonists
In the first six months of 2018

CDC: 8.8 Percent Uninsured in U.S. in First Half of 2018

0
12.5 percent of adults aged 18-64 years and 4.4 percent of children aged 0-17 years uninsured
In a simulation of children with peanut allergy

Epinephrine Personal Autoinjectors Cost-Effective at $24

0
Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24